292 Søkeresultatpipe

Eqva

EQVA strengthens its position in the aquaculture segment through the acquisition of Austevoll Rørteknikk AS3.3.2025 08:04:04 CET | Eqva | Aktuelt

March 3, 2025 – EQVA ASA («EQVA» or the “Company”) has entered into an agreement to acquire 100% of the shares in Austevoll Rørteknikk AS (“ART”). The acquisition will be carried out by EQVA’s wholly owned subsidiary EQVA Industrial Solutions AS (EIS) and aligns with EQVA’s strategy for growth and expansion within industrial services and the aquaculture segment.
Kasakhstans Ambassade i Norge

Eksperter ser sterkt vekstpotensial ettersom Kasakhstan sender første Kashagan-olje via Baku-Tbilisi-Ceyhan14.2.2025 12:12:17 CET | Kasakhstans Ambassade i Norge | Pressemelding

ASTANA – Kasakhstans første sending av råolje fra Kashagan-feltet via Baku-Tbilisi-Ceyhan (BTC) rørledningen signaliserer et voksende partnerskap mellom Kasakhstan og Aserbajdsjan, med potensial for å øke mengdene. Ved slutten av januar sendte Kasakhstan sin første levering av Kashagan-olje, på omtrent 6 000 tonn, gjennom BTC. Eksperter fra Aserbajdsjan har evaluert potensialet og langsiktig levedyktighet. Ifølge Anar Azizov, en økonom fra Aserbajdsjan, er starten på transporten av Kashagan-olje via BTC neste steg i utvidelsen av energisamarbeidet mellom de to landene. "Det bør påpekes at Baku og Astana de siste tre årene har styrket samarbeidet innen energisektoren, spesielt når det gjelder transittransport av kasakhstansk olje. Siden 2022 har Kasakhstan vært på utkikk etter alternativer for å diversifisere sine oljeeksportveier. I denne sammenhengen er Baku klare til å tilby Kasakhstan tilgjengelig kapasitet i BTC," sa Azizov, sitert av Kazinform nyhetsbyrå. Han forutser en økning i

LTS wins funding from BARDA’s Patch Forward Prize Competition for two partnerships14.1.2025 13:36:14 CET | news aktuell GmbH | Press release

14.01.2025 Andernach – LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company, is proud to announces its selection as a Concept Stage winner for two projects in the #PatchForwardPrize, a $50 million challenge by the Biomedical Advanced Research and Development Authority (BARDA) to advance microneedle patch-based RNA vaccine technologies.
news aktuell GmbH

Grünenthal Group: Grünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer9.1.2025 10:53:40 CET | news aktuell GmbH | Press release

Aachen, Germany, 09 January 2025 – Grünenthal announced today that Prof. Dr. Uli Brödl will assume the role of Chief Scientific Officer (CSO) and Member of the Corporate Executive Board, effective 01 February 2025. Uli Brödl has more than 15 years of industry experience. He joins Grünenthal from Boehringer Ingelheim, where he served as Corporate Senior Vice President, Head of Global Clinical Development & Operations, and member of Boehringer Ingelheim's Venture Fund Investment Committee. In his most recent role, he oversaw end-to-end clinical development and operations activities across therapeutic areas and worked at the interface of R&D, Commercial, and Market Access functions. He has a proven track record of bringing innovative medicines to patients, including Empagliflozin, an oral anti-diabetic medicine. Earlier in his career, Uli Brödl led Boehringer Ingelheim's Canadian medical organisation and gained extensive market experience. In parallel, he founded and co-chaired the BI Can
  • 1
  • 2
  • 3
  • 4
  • 5
  • Siste
  • >>
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye